NCT07015437Phase 2Recruiting

A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1

Study sponsor: Cerus Corporation

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-12-15Estimated
Enrollment · participants120Estimated
Source updated2026-09-21Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Planned enrollment increased by 50 participants

Before: 70 participants (planned). After: 120 participants (planned).

Primary completion date changed

Before: 30 Jul 2026. After: 15 Dec 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview